Elizabeth Holmes started Theranos in 2003 and dropped out of Stanford University to revolutionize the medical industry with a better way to analyze blood, with a secret new technology. Over the decade that followed, Theranos came to be valued at 9 billion dollars.

The only problem, the tech didn't work.